Between Scylla and Charybdis: A choice between equally dreadful alternatives

Europace

Volumn 4, Issue 3, 2002, Pages 215-218

  Jordaens, Luc ^a   Szili Torok, Tamas ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR CONDUCTION; CARDIOPULMONARY HEMODYNAMICS; CARDIOVERSION; CATHETER ABLATION; EDITORIAL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY;

ATRIAL FIBRILLATION; CATHETER ABLATION; DECISION MAKING; HEMODYNAMIC PROCESSES; HUMANS;

EID: 0036665279     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2002.0250     Document Type: Editorial

References (18)

1. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981; 245: 1540-4.
2. Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996; 78: 1433-6.
3. Scheinman MM, Evans-Bell T. Catheter ablation of the atrioventricular junction: a report of the percutaneous mapping and ablation registry. Circulation 1984; 70: 1024-9.
4. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000; 75: 790-5.
5. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000; 101: 1138-44.
6. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 1992; 20: 527-32.
7. Evans GT Jr, Scheinman MM, Zipes DP, Benditt D, Breithardt G, Camm AJ, el-Sherif N, Fisher J, Fontaine G, et al.. The Percutaneous Cardiac Mapping and Ablation Registry: final summary of results. Pacing Clin Electrophysiol 1988; 11: 1621-6.
8. Jordaens L, Rubbens L, Vertongen P. Sudden death and long term survival after ablation of the atrioventricular junction. Eur J Cardiac Pacing Electrophysiol 1993; 3: 232-7.
9. Geelen P, Brugada J, Andries E, Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1997; 20: 343-8.
10. Lechat P, Escolano S, Golmard JL, Lardoux H, Witchitz S, Henneman JA, Maisch B, Hetzel M, Jaillon P, Boissel JP, Mallet A. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1997; 96: 2197-205.
11. Rodriguez LM, Smeets JL, Xie B, de Chillou C, Cheriex E, Pieters F, Metzger J, den Dulk K, Wellens HJ. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993; 72: 1137-41.
12. Szili-Torok T, Kimman GP, Theuns D, Poldermans D, Roelandt JR, Jordaens LJ. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Europace 2002; 4: 61-5.
13. Bourke J, Hawkins T, Keavey P, Tynan M, Jamieson S, Behulova R, Furniss S. Evolution of ventricular function during permanent pacing from either right ventricular apex or outflow tract following AV-nodal ablation for atrial fibrillation. Europace 2002; 4: 219-28.
14. Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N, Lolli G. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998; 98: 953-60.
15. Karpawich PP, Rabah R, Haas JE. Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block. Pacing Clin Electrophysiol 1999; 22: 1372-7.
16. Buckingham TA, Candinas R, Attenhofer C, Van Hoeven H, Hug R, Hess O, Jenni R, Amann FW. Systolic and diastolic function with alternate and combined site pacing in the right ventricle. Pacing Clin Electrophysiol 1998; 21: 1077-84.
17. Leclercq C, Victor F, Alonso C, Pavin D, Revault d'Allones G, Bansard JY, Mabo P, Daubert C. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000; 85: 1154-6, A9.
18. Weerasooriya R, Powell A, Szili-Torok T, Whalley D, Kanagaratnam L, Heddle W, Leitch J, Perks A, Ferguson L, Bulsara M, Davis M. The Australian Intervention Randomised Control of rate in Atrial Fibrillation Trial (AIRCRAFT). Pacing Clin Electrophysiol 2002; Suppl. (in press).